Haleon sees higher sales in 2024 as FY profits come in flat
Haleon
353.00p
16:34 26/07/24
1.35%
4.70p
Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
FTSE 100
8,285.71
16:45 26/07/24
n/a
n/a
FTSE 350
4,586.28
16:45 26/07/24
n/a
n/a
FTSE All-Share
4,544.36
16:29 26/07/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,767.31
16:45 26/07/24
1.27%
284.71
The maker of Panadol pain relief, spun out of pharma giant GSK in 2022, posted pre-tax profits of £1.62bn for 2023, up 0.6%. It now expects revenue to rise 4% - 6% this year.
Revenue grew 4.1% to £11.3bn.
Reporting by Frank Prenesti for Sharecast.com